These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16619524)

  • 1. Array-based genomic analysis of screen-detected Gleason score 6 and 7 prostatic adenocarcinomas.
    Postma R; van Marion R; van Duin M; Vissers KJ; Wink JC; Schröder FH; Tanke HJ; Szuhai K; van der Kwast TH; van Dekken H
    Anticancer Res; 2006; 26(2A):1193-200. PubMed ID: 16619524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries.
    Matsuda K; Matsuyama H; Hara T; Yoshihiro S; Oga A; Kawauchi S; Furuya T; Izumi H; Naito K; Sasaki K
    Cancer Genet Cytogenet; 2004 Jul; 152(2):119-23. PubMed ID: 15262429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysis.
    van Dekken H; Paris PL; Albertson DG; Alers JC; Andaya A; Kowbel D; van der Kwast TH; Pinkel D; Schröder FH; Vissers KJ; Wildhagen MF; Collins C
    Genes Chromosomes Cancer; 2004 Mar; 39(3):249-56. PubMed ID: 14732926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic changes in pT2 and pT3 prostate cancer detected by comparative genomic hybridization.
    Fukasawa S; Kino M; Kobayashi M; Suzuki H; Komiya A; Imamoto T; Hirokawa Y; Shiraishi T; Takiguchi M; Ishida H; Shindo T; Seki N; Ichikawa T
    Prostate Cancer Prostatic Dis; 2008; 11(3):303-10. PubMed ID: 17923855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features.
    Alers JC; Krijtenburg PJ; Vis AN; Hoedemaeker RF; Wildhagen MF; Hop WC; van Der Kwast TT; Schröder FH; Tanke HJ; van Dekken H
    Am J Pathol; 2001 Feb; 158(2):399-406. PubMed ID: 11159178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic changes in localized prostate cancer of Japanese patients shown by comparative genomic hybridization.
    Kasahara K; Taguchi T; Yamasaki I; Kamada M; Shuin T
    Cancer Genet Cytogenet; 2005 May; 159(1):84-8. PubMed ID: 15860364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of multifocal prostate cancer by comparative genomic hybridization.
    Kobayashi M; Ishida H; Shindo T; Niwa S; Kino M; Kawamura K; Kamiya N; Imamoto T; Suzuki H; Hirokawa Y; Shiraishi T; Tanizawa T; Nakatani Y; Ichikawa T
    Prostate; 2008 Dec; 68(16):1715-24. PubMed ID: 18781578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate.
    Arora R; Koch MO; Eble JN; Ulbright TM; Li L; Cheng L
    Cancer; 2004 Jun; 100(11):2362-6. PubMed ID: 15160339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.
    Laitinen S; Karhu R; Sawyers CL; Vessella RL; Visakorpi T
    Genes Chromosomes Cancer; 2002 Sep; 35(1):66-73. PubMed ID: 12203791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical dissection of genetic pathways involved in prostate carcinogenesis.
    Ribeiro FR; Diep CB; Jerónimo C; Henrique R; Lopes C; Eknaes M; Lingjaerde OC; Lothe RA; Teixeira MR
    Genes Chromosomes Cancer; 2006 Feb; 45(2):154-63. PubMed ID: 16235241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.
    El Gammal AT; Brüchmann M; Zustin J; Isbarn H; Hellwinkel OJ; Köllermann J; Sauter G; Simon R; Wilczak W; Schwarz J; Bokemeyer C; Brümmendorf TH; Izbicki JR; Yekebas E; Fisch M; Huland H; Graefen M; Schlomm T
    Clin Cancer Res; 2010 Jan; 16(1):56-64. PubMed ID: 20028754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal imbalances in wood dust-related adenocarcinomas of the inner nose and their associations with pathological parameters.
    Korinth D; Pacyna-Gengelbach M; Deutschmann N; Hattenberger S; Bockmühl U; Dietel M; Schroeder HG; Donhuijsen K; Petersen I
    J Pathol; 2005 Oct; 207(2):207-15. PubMed ID: 16041693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic analysis of prostate carcinoma specimens obtained via ultrasound-guided needle biopsy may be of use in preoperative decision-making.
    Teixeira MR; Ribeiro FR; Eknaes M; Waehre H; Stenwig AE; Giercksky KE; Heim S; Lothe RA
    Cancer; 2004 Oct; 101(8):1786-93. PubMed ID: 15386312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple abnormalities detected by dye reversal genomic microarrays in prostate cancer: a much greater sensitivity than conventional cytogenetics.
    Pettus JA; Cowley BC; Maxwell T; Milash B; Stephenson RA; Rohr LR; Hoff C; Brothman AR
    Cancer Genet Cytogenet; 2004 Oct; 154(2):110-8. PubMed ID: 15474145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic markers useful for distinguishing between organ-confined and locally advanced prostate cancer.
    Chu LW; Troncoso P; Johnston DA; Liang JC
    Genes Chromosomes Cancer; 2003 Mar; 36(3):303-12. PubMed ID: 12557230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal and microsatellite instability of adenocarcinomas and dysplastic lesions (DALM) in ulcerative colitis.
    van Dieren JM; Wink JC; Vissers KJ; van Marion R; Hoogmans MM; Dinjens WN; Schouten WR; Tanke HJ; Szuhai K; Kuipers EJ; van der Woude CJ; van Dekken H
    Diagn Mol Pathol; 2006 Dec; 15(4):216-22. PubMed ID: 17122649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.
    van Duin M; van Marion R; Vissers K; Watson JE; van Weerden WM; Schröder FH; Hop WC; van der Kwast TH; Collins C; van Dekken H
    Genes Chromosomes Cancer; 2005 Dec; 44(4):438-49. PubMed ID: 16130124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)--Section Rotterdam. A comparison of two rounds of screening.
    Postma R; Schröder FH; van Leenders GJ; Hoedemaeker RF; Vis AN; Roobol MJ; van der Kwast TH
    Eur Urol; 2007 Jul; 52(1):89-97. PubMed ID: 17257742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.